# OPENEVIDENCE - PE Due Diligence Dashboard (RAG)

*Generated: 2025-11-14T21:11:18.126396*

company_id='openevidence' dashboard='## Company Overview\n**Company Name:** OpenEvidence  \n**Legal Name:** OpenEvidence  \n**Website:** [openevidence.com](https://openevidence.com/)  \n**Headquarters:** Cambridge, MA, USA  \n**Founded Year:** 2025  \n**Categories:** Medical Information Platform, Healthcare Technology, Clinical Research, Data Aggregation, Evidence-Based Medicine  \n\n## Business Model and GTM\nOpenEvidence is described as the leading medical information platform featuring multimedia and clinical findings from The New England Journal of Medicine and JAMA Network specialty journals. The platform is available on iOS and Android for verified U.S. healthcare professionals (HCPs). The company states that OpenEvidence is free and unlimited for health care professionals. Pricing model and tiers are not disclosed.\n\n## Funding & Investor Profile\nOpenEvidence completed a Seed round of funding on January 1, 2025. The investors include notable firms such as Sequoia, Google Ventures, Kleiner Perkins, Coatue, Thrive, Conviction, ICONIQ, Greycroft, Breyer Capital, BOND, Blackstone, and Mayo Clinic. The total amount raised and last disclosed valuation are not disclosed.\n\n## Growth Momentum\nAs of November 5, 2025, OpenEvidence is in its early stages, having just completed its Seed round. There are no disclosed metrics regarding user growth, revenue, or market penetration.\n\n## Visibility & Market Sentiment\nThe company has signed content agreements with JAMA and The New England Journal of Medicine, which may enhance its credibility and visibility in the healthcare sector. The company states that it is the leading medical information platform, which suggests a positive market sentiment, although specific sentiment metrics are not disclosed.\n\n## Risks and Challenges\nNot disclosed.\n\n## Outlook\nOpenEvidence is positioned to serve healthcare professionals with a focus on evidence-based medicine and clinical research. However, as a newly founded company, it faces the typical challenges of market entry, competition, and user acquisition in the healthcare technology space.\n\n## Disclosure Gaps\n- Total amount raised in the Seed round.\n- Last disclosed valuation.\n- Specific metrics regarding user growth, revenue, or market penetration.\n- Detailed risks and challenges faced by the company.' chunks_used=3